IP Verse

Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring - EP3461503B9

PatentPatent Analysis

EP3461503

BIOMARIN PHARMACEUTICAL
Application Number
EP18205446A
Filing Date
Apr 11, 2008
Status
Revoked
Jun 14, 2024
Grant Date
May 11, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3328416B1
EP3138566B1
EP3175863B1

Bibliography

The patent EP3461503B9 was granted to Biomarin Pharmaceutical on May 11, 2022 following the initial filing on Apr 11, 2008 under the application number EP18205446A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CORIPHARMA EHFNov 9, 2022ADMISSIBLE
DIPHARMANov 9, 2022WITHDRAWN
BETAPHARM ARZNEIMITTELOct 28, 2022ADMISSIBLE
SANDOZOct 12, 2022ADMISSIBLE
STADA ARZNEIMITTELOct 5, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents